Transarterial chemoembolization plus apatinib with or without camrelizumab for unresected hepatocellular carcinoma: A two-center propensity score matching study by Di Zhu, Kun Ma, Wei Yang, Hai-Feng Zhou, Qi Shi, Jian-Wu Ren, Yu-Guan Xie, Sheng Liu, Hai-Bin Shi, Wei-Zhong Zhou

Get full text